Loading…
Sensei Biotherapeutics Inc is projected to rise to $19.60 by 2027, a +42% move from its current price of $13.85. SNSE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $12.82 | $13.84 | $14.94 | -0.09% |
| Aug 2 | $12.41 | $13.82 | $15.40 | -0.18% |
| Aug 3 | $12.10 | $13.81 | $15.77 | -0.27% |
| Aug 4 | $11.84 | $13.80 | $16.08 | -0.36% |
| Aug 5 | $11.62 | $13.79 | $16.36 | -0.45% |
| Aug 6 | $11.42 | $13.78 | $16.61 | -0.54% |
| Aug 7 | $11.24 | $13.76 | $16.85 | -0.63% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $11.24 | $13.76 | $16.85 | -0.63% |
| Week 2 | $10.27 | $13.68 | $18.21 | -1.26% |
| Week 3 | $9.57 | $13.59 | $19.29 | -1.88% |
| Week 4 | $9.01 | $13.50 | $20.24 | -2.50% |
| Week 5 | $8.54 | $13.42 | $21.09 | -3.11% |
| Week 6 | $8.12 | $13.33 | $21.89 | -3.73% |
| Week 7 | $7.76 | $13.25 | $22.63 | -4.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors.
The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Sensei Biotherapeutics Inc (SNSE) is a healthcare stock positioned in the biotechnology sector.
The stock trades at $13.85 per share and has a market cap of $18.59M, ranking 4947 by market capitalization.
The forecast shows a long-term upside with a 2050 average price of $53.19 and a max of $122.33, implying a 284% ROI in 2050. The 2026 forecast is neutral with an average price of $13.85, aligning with the current level.
A major floor 61.3% below — a decisive break under it would weaken the trend.
The nearest floor, 22.1% below — buyers have tended to step in here.
The nearest ceiling, 80.5% above — a clean break opens room to run.
A major ceiling 153.2% above — clearing it would confirm fresh momentum.
Key SNSE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SNSE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $23.53 | Sell | $23.38 | Sell |
| MA 10 | $23.20 | Sell | $22.31 | Sell |
| MA 20 | $18.49 | Sell | $20.71 | Sell |
| MA 50 | $21.01 | Sell | $20.98 | Sell |
| MA 100 | $24.44 | Sell | $20.86 | Sell |
| MA 200 | $17.09 | Sell | $18.37 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.36 | Neutral |
| Stoch RSI (14) | 71.28 | Neutral |
| CCI (20) | 61.83 | Neutral |
| Williams %R (14) | -17.33 | Info |
| MACD (12,26,9) | 0.89 | Buy |
| ROC (12) | 65.49 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 82.67 | Sell |
| TRIX (15) | 0.30 | Buy |
| Awesome (5,34) | 5.21 | Buy |
| Ultimate (7,14,28) | 55.10 | Neutral |
| Momentum (10) | 5.66 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 23.80 | Sell |
| ADX (14) | 25.71 | Buy |
| ATR (14) | 1.29 | Info |
The 30-day technical picture is bullish. The RSI14 reads 60, supporting a constructive stance.
The stock shows a 50-day simple moving average of $21.01 and a 200-day simple moving average of $17.09, indicating price momentum toward the mid-teens to low twenties.
Price action sits between a support of $10.79 and a resistance of $25.00, with a 30-day price range from $8.37 to $22.93.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.75 | $13.85 | $17.23 | 0% | Neutral | |
| $14.21 | $19.60 | $29.22 | +42% | Bullish | |
| $14.04 | $20.57 | $32.67 | +49% | Bullish | |
| $12.66 | $19.53 | $32.57 | +41% | Bullish | |
| $11.30 | $18.29 | $31.75 | +32% | Bullish | |
| $10.80 | $18.26 | $32.82 | +32% | Bullish | |
| $11.81 | $20.83 | $38.59 | +50% | Bullish | |
| $13.91 | $25.55 | $48.65 | +84% | Bullish | |
| $15.96 | $30.49 | $59.53 | +120% | Bullish | |
| $15.19 | $30.17 | $60.27 | +118% | Bullish | |
| $21.43 | $47.61 | $104.53 | +244% | Bullish | |
| $23.93 | $53.19 | $122.33 | +284% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.75 | $13.85 | $17.42 | +0.00% |
| August 2026 | $10.95 | $13.28 | $16.78 | -4.11% |
| September 2026 | $10.37 | $12.75 | $16.45 | -3.97% |
| October 2026 | $10.85 | $13.50 | $17.71 | +5.83% |
| November 2026 | $10.72 | $13.48 | $17.94 | -0.13% |
| December 2026 | $10.06 | $12.78 | $17.23 | -5.21% |
Click any year to see its month-by-month SNSE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Sensei Biotherapeutics Inc's 2026 outlook centres on $13.85, within a $8.75 to $17.23 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SNSE could reach as high as $29.22, with a base case around $19.60 and support toward $14.21 — roughly +42% from $13.85. Buyers look set to stay in control over this stretch.
Expect SNSE to range from $14.04 to $32.67 through 2028. The $20.57 average target implies a +49% move from current prices. That is up +5% on the projected 2027 average. Momentum favours further upside here.
The SNSE price prediction for 2029 points to an average of $19.53 (low $12.66, high $32.57) — a potential gain of +41% on today's $13.85. Buyers look set to stay in control over this stretch.
In 2030, SNSE is projected to trade between $11.30 and $31.75, averaging $18.29 — a potential gain of +32% from today's $13.85. That is -6% versus the projected 2029 average. Momentum favours further upside here.
Sensei Biotherapeutics Inc's 2031 outlook centres on $18.26, within a $10.80 to $32.82 range. That is 0% versus the projected 2030 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SNSE could reach as high as $38.59, with a base case around $20.83 and support toward $11.81 — roughly +50% from $13.85. Momentum favours further upside here.
Expect SNSE to range from $13.91 to $48.65 through 2033. The $25.55 average target implies a +84% move from current prices. That is up +23% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SNSE price prediction for 2034 points to an average of $30.49 (low $15.96, high $59.53) — a potential gain of +120% on today's $13.85. Momentum favours further upside here.
In 2035, SNSE is projected to trade between $15.19 and $60.27, averaging $30.17 — a potential gain of +118% from today's $13.85. That is -1% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Sensei Biotherapeutics Inc's 2040 outlook centres on $47.61, within a $21.43 to $104.53 range. That is up +58% on the projected 2035 average. That marks a +244% change versus current levels. Momentum favours further upside here.
By 2050, SNSE could reach as high as $122.33, with a base case around $53.19 and support toward $23.93 — roughly +284% from $13.85. Buyers look set to stay in control over this stretch.
Investing $1,000 in SNSE today (≈ 72.202166 SNSE) could be worth
$3,840.22
+$2,840.22 (+284%) by 2050 · US Dollar
Based on the average projected SNSE price of $53.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SNSEwould be worth at today's price.
$1,000 invested in SNSE on Jul 2, 2025 (≈ 107.933077 SNSE) would be worth
$1,494.87
+$494.87 (+49.5%) today · 1.49× · US Dollar
Based on a SNSE entry price of $9.27 vs. today's $13.85.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $24.67 | $561.41 | -43.9% |
| 1 month ago | $16.09 | $860.52 | -13.9% |
| 3 months ago | $31.02 | $446.49 | -55.4% |
| 6 months ago | $9.65 | $1,435.98 | +43.6% |
| 1 year ago | $9.27 | $1,494.87 | +49.5% |
| All time (4.9y) ago | $150 | $92.33 | -90.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SNSE forecast.
Our base-case forecast reaches $28.00 around 2034.
Implied market cap at $28.00: $37.57M
The multi-year forecast depicts a bullish trajectory for SNSE, with higher averages and meaningful upside over time. From 2027 to 2028 the average price climbs to the high teens, while 2030 shows an average of $18.29 with a max of $31.75 (ROI 32.1%).
The forecast continues to show strong upside into the 2030s and 2040s, including 2040 with an average of $47.61 and a max of $104.53 (ROI 243.8%). By 2050 the average is $53.19 and the max is $122.33, with an implied ROI of 284% and a bullish sentiment.
These are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
The forecast shows an average price of $18.29, with a min of $11.30 and a max of $31.75, and a projected ROI of 32.1%. Sentiment is BULLISH.
Forecasts indicate bullish sentiment in multiple years from 2027 onward, with the average price rising to $53.19 by 2050 and a projected ROI of 284%. Note that 2026 is neutral with an average price of $13.85 and ROI of 0%.
Yes. The forecast's maximum prices exceed $50 in several years, with a max of $60.27 in 2035, $59.53 in 2034, $104.53 in 2040, and $122.33 in 2050.
RSI14 is 60 with a bullish sentiment. The 50-day SMA is $21.01 and the 200-day SMA is $17.09. Support is at $10.79 and resistance at $25.00; the 30-day range is $8.37 to $22.93.
Current price is $13.85 and market cap is $18.59M. The stock ranks 4947 by market capitalization.
Sensei Biotherapeutics Inc Community Discussion
0Share your Sensei Biotherapeutics Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.